Integral DiagnosticsASX:IDX -0.50%73 OCF Margin % is 8.35% as of Dec. 2025, which is 42% below its 10-year median of 14.32. GuruFocus rates ASX:IDX with a GF Score™ of 73/100 and a GF Value™ of A$2.78 (Modestly Undervalued). The stock has 9 warning signs investors should review. Among 204 Medical Diagnostics & Research companies, Integral Diagnostics ranks better than 60.29% on this metric.
The historical rank and industry rank for Integral Diagnostics's OCF Margin % or its related term are showing as below:
ASX:IDX'
s OCF Margin % Range Over the Past 10 Years
Min: 10.34 Med: 14.32 Max: 19.95
Current: 11
During the past 10 years, the highest OCF Margin % of Integral Diagnostics was 19.95%. The lowest was 10.34%. And the median was 14.32%.
ASX:IDX's OCF Margin % is ranked better than 60.29% of 204
companies
in the Medical Diagnostics & Research industry
Industry Median: 4.755
vs ASX:IDX: 11.00
Integral Diagnostics OCF Margin % Related Terms
Integral Diagnostics OCF Margin % Historical Data
* Premium members only.
The historical data trend for Integral Diagnostics's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:IDX vs TMO, DHR, IDXX: OCF Margin % Comparison
For the Diagnostics & Research subindustry, Integral Diagnostics's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Integral Diagnostics OCF Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Integral Diagnostics's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Integral Diagnostics's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Integral Diagnostics (ASX:IDX) has a OCF Margin % of 8.35% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Integral Diagnostics and its competitors. This is 42% below median its historical median of 14.32. Over the past decade, Integral Diagnostics' OCF Margin % has ranged from 10.34 to 19.95. According to the industry distribution chart, Integral Diagnostics ranks #81 out of 204 companies in the Medical Diagnostics & Research industry, placing it in the top 39.7%.
Is Integral Diagnostics' OCF Margin % too high?
Integral Diagnostics' current OCF Margin % of 8.35% is 42% below median its 10-year median of 14.32. Over the past 10 years, this metric has ranged from a low of 10.34 to a high of 19.95. The Medical Diagnostics & Research industry median OCF Margin % is 4.76. Integral Diagnostics' value of 8.35% is 75.6% above this industry median. Based on the distribution chart, Integral Diagnostics ranks #81 out of 204 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Integral Diagnostics has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Integral Diagnostics' OCF Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Integral Diagnostics ranks #81 out of 204 companies for OCF Margin %. This puts Integral Diagnostics in the upper half of its industry. The industry median OCF Margin % is 4.76. Integral Diagnostics' value of 8.35% is 75.6% above this benchmark. Historically, Integral Diagnostics' own OCF Margin % has ranged from 10.34 to 19.95 over the past decade. While the company's 10-year median is 14.32 vs. the industry median of 4.76, Integral Diagnostics has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Diagnostics & Research company?
The median OCF Margin % among Medical Diagnostics & Research companies is 4.76, based on 204 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Integral Diagnostics's current OCF Margin % of 8.35% is 75.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Integral Diagnostics and its competitors. For the Medical Diagnostics & Research industry, the median OCF Margin % is 4.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Integral Diagnostics's current OCF Margin % is 8.35%, which is 42% below median its own 10-year median of 14.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Integral Diagnostics stock overvalued right now?
Based on GuruFocus' analysis, Integral Diagnostics (ASX:IDX) is currently considered Modestly Undervalued. The stock's GF Value™ is A$2.78, compared to a current price of A$2.00 — trading 28.1% below its estimated fair value. The current OCF Margin % is 8.35%, which is 42% below median its 10-year median of 14.32 and 75.6% above the Medical Diagnostics & Research industry median of 4.76. Integral Diagnostics' overall GF Score™ is 73/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Integral Diagnostics (ASX:IDX), the current OCF Margin % is 8.35% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Integral Diagnostics (ASX:IDX) Overvalued in 2026?
Based on GuruFocus' analysis, Integral Diagnostics stock appears to be undervalued.
The current stock price of A$2.00 is trading 28.1% below its estimated GF Value™ of A$2.78.
GuruFocus considers Integral Diagnostics to be Modestly Undervalued.
Key valuation signals for ASX:IDX:
OCF Margin %: 8.35% (42% below median its 10-year median of 14.32)
GF Value™: A$2.78 vs. price of A$2.00 (28.1% below fair value)
Industry Position: 75.6% above the Medical Diagnostics & Research median (#81 of 204)
No single metric tells the full story. See the ASX:IDX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Integral Diagnostics is a major Australian diagnostic imaging provider. In Australia, imaging revenues are almost entirely earned via the public health Medicare system. Integral typically earns approximately 90% of group revenue from diagnostic imaging in Australia and the remainder from diagnostic imaging in Auckland, New Zealand. In Australia, Integral services regional areas in Queensland, Victoria, New South Wales, and Western Australia.
73GF Score
Get the complete analysis for ASX:IDX
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:IDX has been successfully added to your 
